| Serial Number | 79378366 |
| Word Mark | BAMURIK |
| Filing Date | Thursday, July 20, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Thursday, September 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceuticals for the treatment of multiple sclerosis |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 8, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cycle Pharmaceuticals Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, September 7, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, September 8, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 12, 2023 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 25, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, March 26, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, March 25, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, April 12, 2024 | REFUSAL PROCESSED BY MPU |
| Wednesday, September 18, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 18, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 19, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 8, 2024 | REFUSAL PROCESSED BY IB |
| Friday, April 12, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |